Hyperhep-B S/D

Hyperhep-B S/D

hepatitis b immunoglobulin

Manufacturer:

Dipa Pharmalab Intersains
Concise Prescribing Info
Contents
Human hepatitis B Ig
Indications/Uses
Post-exposure prophylaxis of hepatitis: acute exposure to blood containing HBsAg, perinatal exposure of infants born to HBsAg positive mothers, sexual exposure to an HBsAg positive person, household exposure to persons w/ acute HBV infection.
Dosage/Direction for Use
IM Acute exposure to blood containing HBsAg 0.06 mL/kg w/in 7 days of exposure. Prophylaxis of infant born to HBsAg & HBeAg positive mother 0.5 mL to be given w/in 12 hr of birth. Sexual exposure to an HBsAg positive person 0.06 mL/kg as single dose w/in 14 days of the last sexual contact. Household exposure to persons w/ acute HBV infection Infant <12 mth 0.5 mL.
Special Precautions
Prior systemic allergic reactions to human Ig, severe thrombocytopenia, coagulation disorder. Pregnancy.
Adverse Reactions
Local pain & tenderness at the inj site, urticaria & angioedema, anaphylactic reactions.
Drug Interactions
Live virus vaccines.
ATC Classification
J06BB04 - hepatitis B immunoglobulin ; Belongs to the class of specific immunoglobulins. Used in passive immunizations.
Presentation/Packing
Form
Hyperhep-B S/D inj 220 IU/mL
Packing/Price
0.5 mL x 1's (Rp2,277,000/pre-filled syringe)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in